SUN PHARMA ADVANCED RESEARCH COMPANY
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Income Statement History
[Consolidated]
| Mar2024 | Mar2023 | |
|---|---|---|
| INCOME : | ||
| Operating Income | ₹76 Cr | ₹239 Cr |
| Sales | - | - |
| Job Work/ Contract Receipts | - | - |
| Processing Charges / Service Income | ₹76 Cr | ₹239 Cr |
| Revenue from property development | - | - |
| Other Operational Income | - | - |
| Less: Excise Duty | - | - |
| Operating Income (Net) | ₹76 Cr | ₹239 Cr |
| EXPENDITURE : | ||
| Increase/Decrease in Stock | - | - |
| Raw Material Consumed | - | - |
| Opening Raw Materials | - | - |
| Purchases Raw Materials | - | - |
| Closing Raw Materials | - | - |
| Other Direct Purchases / Brought in cost | - | - |
| Other raw material cost | - | - |
| Power & Fuel Cost | ₹6.14 Cr | ₹5.75 Cr |
| Electricity & Power | ₹6.14 Cr | ₹5.75 Cr |
| Oil, Fuel & Natural gas | - | - |
| Coals etc | - | - |
| Other power & fuel | - | - |
| Employee Cost | ₹142 Cr | ₹107 Cr |
| Salaries, Wages & Bonus | ₹129 Cr | ₹98 Cr |
| Contributions to EPF & Pension Funds | ₹5.62 Cr | ₹4.36 Cr |
| Workmen and Staff Welfare Expenses | ₹5.04 Cr | ₹3.11 Cr |
| Other Employees Cost | ₹1.80 Cr | ₹1.97 Cr |
| Operating Expenses | ₹140 Cr | ₹180 Cr |
| Sub-contracted / Out sourced services | - | - |
| Processing Charges | ₹4.44 Cr | ₹3.57 Cr |
| Repairs and Maintenance | - | - |
| Packing Material Consumed | - | - |
| Other Mfg Exp | ₹136 Cr | ₹177 Cr |
| General and Administration Expenses | ₹182 Cr | ₹155 Cr |
| Rent , Rates & Taxes | ₹0.38 Cr | ₹0.14 Cr |
| Insurance | ₹1.20 Cr | ₹0.76 Cr |
| Printing and stationery | ₹8.35 Cr | ₹8.63 Cr |
| Professional and legal fees | ₹156 Cr | ₹134 Cr |
| Traveling and conveyance | ₹5.22 Cr | ₹3.88 Cr |
| Other Administration | ₹11 Cr | ₹7.76 Cr |
| Selling and Distribution Expenses | - | - |
| Advertisement & Sales Promotion | - | - |
| Sales Commissions & Incentives | - | - |
| Freight and Forwarding | - | - |
| Handling and Clearing Charges | - | - |
| Other Selling Expenses | - | - |
| Miscellaneous Expenses | ₹7.23 Cr | ₹4.87 Cr |
| Bad debts /advances written off | - | - |
| Provision for doubtful debts | ₹2.05 Cr | - |
| Losson disposal of fixed assets(net) | - | ₹0.11 Cr |
| Losson foreign exchange fluctuations | ₹3.10 Cr | ₹2.07 Cr |
| Losson sale of non-trade current investments | - | - |
| Other Miscellaneous Expenses | ₹2.08 Cr | ₹2.69 Cr |
| Less: Expenses Capitalised | - | - |
| Total Expenditure | ₹478 Cr | ₹453 Cr |
| Operating Profit (Excl OI) | ₹-402 Cr | ₹-214 Cr |
| Other Income | ₹29 Cr | ₹11 Cr |
| Interest Received | ₹25 Cr | ₹7.60 Cr |
| Dividend Received | - | - |
| Profit on sale of Fixed Assets | ₹0.58 Cr | - |
| Profits on sale of Investments | - | - |
| Provision Written Back | - | - |
| Foreign Exchange Gains | - | - |
| Others | ₹3.41 Cr | ₹3.28 Cr |
| Operating Profit | ₹-373 Cr | ₹-203 Cr |
| Interest | ₹1.70 Cr | ₹7.64 Cr |
| InterestonDebenture / Bonds | - | - |
| Interest on Term Loan | ₹0.16 Cr | ₹7.15 Cr |
| Intereston Fixed deposits | - | - |
| Bank Charges etc | ₹0.50 Cr | - |
| Other Interest | ₹1.04 Cr | ₹0.49 Cr |
| PBDT | ₹-374 Cr | ₹-211 Cr |
| Depreciation | ₹13 Cr | ₹12 Cr |
| Profit Before Taxation & Exceptional Items | ₹-387 Cr | ₹-223 Cr |
| Exceptional Income / Expenses | - | - |
| Profit Before Tax | ₹-387 Cr | ₹-223 Cr |
| Provision for Tax | ₹0.38 Cr | - |
| Current Income Tax | ₹1.63 Cr | - |
| Deferred Tax | ₹-1.25 Cr | - |
| Other taxes | - | - |
| Profit After Tax | ₹-387 Cr | ₹-223 Cr |
| Extra items | - | - |
| Minority Interest | - | - |
| Share of Associate | - | - |
| Other Consolidated Items | - | - |
| Consolidated Net Profit | ₹-387 Cr | ₹-223 Cr |
| Adjustments to PAT | - | - |
| Profit Balance B/F | ₹-1,592 Cr | ₹-1,371 Cr |
| Appropriations | ₹-1,979 Cr | ₹-1,593 Cr |
| General Reserves | - | - |
| Proposed Equity Dividend | - | - |
| Corporate dividend tax | - | - |
| Other Appropriation | ₹-0.19 Cr | ₹-1.35 Cr |
| Equity Dividend % | - | - |
| Earnings Per Share | ₹-11.93 | ₹-6.86 |
| Adjusted EPS | ₹-11.93 | ₹-6.86 |
Compare Income Statement of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,854.5 Cr | -2.1% | 1.3% | -51.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹25,345.7 Cr | -13.1% | -12% | -7.2% | Stock Analytics | |
| SAGILITY INDIA | ₹19,141.9 Cr | -5.3% | -5.7% | NA | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹8,328.0 Cr | 1.8% | 5.9% | -18.2% | Stock Analytics | |
| JUST DIAL | ₹7,850.7 Cr | -10.3% | 6.4% | -12.2% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹4,678.2 Cr | 0.2% | 6.6% | NA | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -2.1% |
1.3% |
-51.1% |
| SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses
